Controversies about Extended-Spectrum and AmpC Beta-Lactamases
Open Access
- 1 March 2001
- journal article
- review article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 7 (2) , 333-336
- https://doi.org/10.3201/eid0702.010238
Abstract
Volume 22, Number 8—August 2016 - Emerging Infectious Disease journal - CDCKeywords
This publication has 45 references indexed in Scilit:
- Russian Klebsiella pneumoniae isolates that express extended-spectrum β-lactamasesClinical Microbiology & Infection, 2000
- Editorial Response: Extended-Spectrum -Lactamases: A Call for Improved Detection and ControlClinical Infectious Diseases, 1999
- Molecular characterization of a multiply resistant Klebsiella pneumoniae encoding ESBLs and a plasmid-mediated AmpCJournal of Antimicrobial Chemotherapy, 1999
- TEM-24 Produced by Four Different Species of Enterobacteriaceae , Including Providencia rettgeri , in a Single PatientAntimicrobial Agents and Chemotherapy, 1999
- Variability of chromosomally encoded beta-lactamases from Klebsiella oxytocaAntimicrobial Agents and Chemotherapy, 1997
- Ceftazidime-Resistant Klebsiella pneumoniae Isolates Recovered at the Cleveland Department of Veterans Affairs Medical CenterClinical Infectious Diseases, 1996
- Incidence of strains producing extended spectrum β-lactamases in ArgentinaInfection, 1989
- Extended-spectrum beta-lactamasesAntimicrobial Agents and Chemotherapy, 1989
- Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion testsAntimicrobial Agents and Chemotherapy, 1988
- Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescensInfection, 1983